Company Data

Moleculin Biotech Inc.

Ticker
MBRX
Current Price
$1.28 -8.57%
Market Cap
$3.8M
Price Target
Refer to Report
Volume
1.6M
52wk Range
$0.3975 - $10.35
Advanced Market Data

Overview

Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy